Metoclopramide induced growth hormone release in hypogonadal males.
The growth hormone (GH) response to 10 mg intravenous metoclopramide (MCP) ('Maxolon'--Beecham Laboratories) was determined in ten hypogonadal adult males. All the subjects responded with a peak growth hormone level greater than 14 mU/l within 1 hour of administration of MCP. Seven normal adult males did not respond to MCP administration. It is concluded that MCP stimulation may be a useful test for both prolactin and growth hormone reserve in hypogonadal males.
D000293:Adolescent; D000328:Adult; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D007006:Hypogonadism / Q000503:physiopathology*; D007700:Kinetics; D008297:Male; D008787:Metoclopramide; D013737:Testis / Q000503:physiopathology
D013006:Growth Hormone; D008787:Metoclopramide